CPMA Medical Auditor study materials
CPMA Medical Auditor study resources

A Level 5 Exacerbation Visit with a Cloned Exam and a Same-Day Nebulizer

CPMA Medical Auditor · Put your knowledge to work in context.

All case studies

A Level 5 Exacerbation Visit with a Cloned Exam and a Same-Day Nebulizer

A family nurse practitioner documents this established-patient visit for a 68-year-old with COPD and type 2 diabetes. Chief complaint: shortness of breath. HPI: worse today, using the rescue inhaler more often. The physical exam section is character-for-character identical to the note from the visit three months earlier, including a line reading CN I-XII intact, which is not relevant to the complaint. Assessment and plan: COPD exacerbation - albuterol nebulizer administered in office, prednisone burst, continue Symbicort; diabetes - A1c 8.9 today, increase metformin to 1000 mg twice daily, order dilated retinal exam. No time statement is documented. The claim was billed as 99215-25 with 94640. The coder says the note looked strong because the exam was complete.

1. What level of service does the documentation support, and was 99215 correct?

Read the worked answer

Apply the current office/outpatient E/M medical decision making framework element by element.

  • Problems: COPD with exacerbation is a chronic illness with exacerbation - moderate. Uncontrolled type 2 diabetes with a medication change is a chronic illness with progression - moderate.
  • Data: an A1c result reviewed and a retinal exam ordered. Ordering a test is the lowest data category and does not reach moderate on its own.
  • Risk: prescription drug management (prednisone burst, metformin dose increase) - moderate.

Result: two of three elements at moderate = moderate MDM = 99214.

99215 requires high complexity: for example, an acute illness with systemic symptoms where the decision is hospitalization or escalation, or drug therapy requiring intensive monitoring for toxicity. Neither is documented. The exacerbation is treated in the office with oral steroids and a nebulizer; that is the definition of moderate, not high.

Do not give weight to the exam. Under the current framework the exam does not drive the level, and in any case this exam cannot be credited (see below). The coder's reasoning - that a complete exam justifies a higher level - is a pre-2021 habit and is itself a training issue.

Overpayment: the difference between the 99215 and 99214 allowables, not the full claim. The service was rendered and is payable; the level is wrong.

2. Was modifier 25 on the E/M appropriate given that 94640 was billed the same day?

Read the worked answer

Modifier 25 is supportable here - but for a reason the note barely earns.

  • The test is whether the E/M was a significant, separately identifiable service above and beyond the usual work of the procedure. 94640 is the nebulizer treatment for the acute dyspnea; assessment and management of the same exacerbation is normally part of that service and does not, by itself, justify a separate E/M.
  • What saves this claim is the diabetes content: A1c review, a metformin dose increase, and an order for a retinal exam. That is a distinct problem with its own management decision, unrelated to the nebulizer.
  • So the modifier is defensible, but the auditor should note how thin the margin is. If the diabetes paragraph were absent, modifier 25 would fail and the entire E/M payment would be at risk, not just the differential.
  • Education point: the note should make the separateness obvious rather than leaving the auditor to reconstruct it. Encourage a clear statement of the separate problem addressed, or at minimum a plan section organized by problem so the distinct service is self-evident.

Do not, however, use the modifier-25 finding to inflate the error rate. The E/M is payable; only the level is unsupported.

3. How should the auditor handle the exam section that is identical to the prior note?

Read the worked answer

Treat it as unsupported and say so explicitly.

  • Documentation that is copy-forwarded, including a cranial nerve line irrelevant to a respiratory complaint, is cloned documentation. Medicare contractors run copy-paste analytics, and the presence of identical blocks across visits is a program-integrity flag regardless of whether it changed payment.
  • The exam cannot be credited toward any level, and the auditor should not let it lend weight to the reviewer's impression of the visit.
  • Query, but understand the limit of a query. A non-leading query can ask the provider to confirm what was actually performed and documented. A query cannot manufacture documentation that does not exist, and a reconstructed exam written weeks later creates its own record-integrity problem. If the provider confirms the exam was not performed, the note must be corrected, not supplemented.
  • Assess whether it is systemic. Pull five to ten of this provider's other notes and check for the same block. One cloned note is an education issue; a template that stamps the same exam on every chart is a documentation-integrity finding for the compliance committee and possibly an EHR build problem.
  • Quantify honestly. In this claim the cloned exam did not change payment, because MDM drove the level and the error is the level differential. Say that in the report. Finding a documentation defect and then assigning it a dollar value it does not carry destroys the report's credibility when the provider's counsel reads it.